Tandon A, Dinkin M. Transient Vision Loss. International Ophthalmology Clinics. 2019. [QxMD MEDLINE Link].
Tadi P, Najem K, Margolin E. Amaurosis Fugax. 2022 Jan. [QxMD MEDLINE Link]. [Full Text].
Xie JS, Donaldson L, Margolin E. Papilledema: A review of etiology, pathophysiology, diagnosis, and management. Surv Ophthalmol. 2022 Jul-Aug. 67 (4):1135-1159. [QxMD MEDLINE Link].
Jena S, Tripathy K. 2022 Jan. [Full Text].
Blair K, Czyz CN. Retinal Detachment. 2022 Jan. [QxMD MEDLINE Link]. [Full Text].
Castañeda S, Prieto-Peña D, Vicente-Rabaneda EF, Triguero-Martínez A, Roy-Vallejo E, Atienza-Mateo B, et al. Advances in the Treatment of Giant Cell Arteritis. J Clin Med. 2022 Mar 13. 11 (6):[QxMD MEDLINE Link].
Hedges TR. The terminology of transient visual loss due to vascular insufficiency. Stroke. 1984 Sep-Oct. 15(5):907-8. [QxMD MEDLINE Link].
Pula JH, Kwan K, Yuen CA, Kattah JC. Update on the evaluation of transient vision loss. Clin Ophthalmol. 2016. 10:297-303. [QxMD MEDLINE Link].
Vodopivec I, Rizzo JF 3rd. Ophthalmic manifestations of giant cell arteritis. Rheumatology (Oxford). 2018 Feb 1. 57 (suppl_2):ii63-ii72. [QxMD MEDLINE Link].
Dattilo M, Newman NJ, Biousse V. Acute retinal arterial ischemia. Ann Eye Sci. 2018 Jun. 3:[QxMD MEDLINE Link].
Andersen CU, Marquardsen J, Mikkelsen B, Nehen JH, Pedersen KK, Vesterlund T. Amaurosis fugax in a Danish community: a prospective study. Stroke. 1988 Feb. 19 (2):196-9. [QxMD MEDLINE Link].
Shinar Z, Chan L, Orlinsky M. Use of ocular ultrasound for the evaluation of retinal detachment. J Emerg Med. 2011 Jan. 40(1):53-7. [QxMD MEDLINE Link].
Wray SH. Visual aspects of extracranial internal carotid artery disease. Bernstein EF, ed. Amaurosis Fugax. New York: Springer-Verlag; 1988. 72-80.
Hayreh SS. Intra-arterial thrombolysis for central retinal artery occlusion. Br J Ophthalmol. 2008 May. 92(5):585-7. [QxMD MEDLINE Link].
Patel A, Nguyen C, Lu S. Central Retinal Vein Occlusion: A Review of Current Evidence-based Treatment Options. Middle East Afr J Ophthalmol. 2016 Jan-Mar. 23 (1):44-8. [QxMD MEDLINE Link].
Braithwaite T, Nanji AA, Greenberg PB. Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion. Cochrane Database Syst Rev. 2010 Oct 6. CD007325. [QxMD MEDLINE Link].
Chan MMH, Thomas AS, Yoon SP, Leitner D, Fekrat S. Clinical Characteristics of Patients With CRVO in One Eye With Subsequent RVO in The Fellow Eye: A Retrospective Observational Study. Ophthalmic Surg Lasers Imaging Retina. 2019 Jul 1. 50 (7):444-449. [QxMD MEDLINE Link].
Berker N, Batman C. Surgical treatment of central retinal vein occlusion. Acta Ophthalmol. 2008 May. 86(3):245-52. [QxMD MEDLINE Link].
Wittström E. Central Retinal Vein Occlusion in Younger Swedish Adults: Case Reports and Review of the Literature. Open Ophthalmol J. 2017. 11:89-102. [QxMD MEDLINE Link].
Morley MG, Heier JS. Venous obstructive diseases of the retina. Yanoff M, Duker Js. Ophthalmology. 3rd. place unknown: Mosby; Dec 2008. 10/6.17. [Full Text].
Newman NJ, Scherer R, Langenberg P, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol. 2002 Sep. 134(3):317-28. [QxMD MEDLINE Link].
Kalaria C, Kittner S. The therapeutic value of laboratory testing for hypercoagulable states in secondary stroke prevention. Neurol Clin. 2015 May. 33 (2):501-13. [QxMD MEDLINE Link].
Sun X, Dai Y, Chen Y, Yu DY, Cringle SJ, Chen J, et al. Primary angle closure glaucoma: What we know and what we don't know. Prog Retin Eye Res. 2017 Mar. 57:26-45. [QxMD MEDLINE Link].
Tarongoy P, Ho CL, Walton DS. Angle-closure glaucoma: the role of the lens in the pathogenesis, prevention, and treatment. Surv Ophthalmol. 2009 Mar-Apr. 54 (2):211-25. [QxMD MEDLINE Link].
Ng WS, Ang GS, Azuara-Blanco A. Laser peripheral iridoplasty for angle-closure. Cochrane Database Syst Rev. 2012 Feb 15. 2:CD006746. [QxMD MEDLINE Link].
Hayreh SS. Pathogenesis of optic disc edema in raised intracranial pressure. Prog Retin Eye Res. 2016 Jan. 50:108-44. [QxMD MEDLINE Link].
Rigi M, Almarzouqi SJ, Morgan ML, Lee AG. Papilledema: epidemiology, etiology, and clinical management. Eye Brain. 2015. 7:47-57. [QxMD MEDLINE Link].
Chen JJ, Bhatti MT. Papilledema. Int Ophthalmol Clin. 2019 Summer. 59 (3):3-22. [QxMD MEDLINE Link].
McCafferty B, McClelland CM, Lee MS. The diagnostic challenge of evaluating papilledema in the pediatric patient. Taiwan J Ophthalmol. 2017 Jan-Mar. 7 (1):15-21. [QxMD MEDLINE Link].
Meyerson C, Van Stavern G, McClelland C. Leber hereditary optic neuropathy: current perspectives. Clin Ophthalmol. 2015. 9:1165-76. [QxMD MEDLINE Link].
Loporchio D, Mukkamala L, Gorukanti K, Zarbin M, Langer P, Bhagat N. Intraocular foreign bodies: A review. Surv Ophthalmol. 2016 Sep-Oct. 61 (5):582-96. [QxMD MEDLINE Link].
Liu Y, Wang S, Li Y, Gong Q, Su G, Zhao J. Intraocular Foreign Bodies: Clinical Characteristics and Prognostic Factors Influencing Visual Outcome and Globe Survival in 373 Eyes. J Ophthalmol. 2019. 2019:5208092. [QxMD MEDLINE Link].
Ahmadieh H, Soheilian M, Sajjadi H, Azarmina M, Abrishami M. Vitrectomy in ocular trauma. Factors influencing final visual outcome. Retina. 1993. 13 (2):107-13. [QxMD MEDLINE Link].
Fujikawa A, Mohamed YH, Kinoshita H, Matsumoto M, Uematsu M, Tsuiki E, et al. Visual outcomes and prognostic factors in open-globe injuries. BMC Ophthalmol. 2018 Jun 8. 18 (1):138. [QxMD MEDLINE Link].
Feltgen N, Walter P. Rhegmatogenous retinal detachment--an ophthalmologic emergency. Dtsch Arztebl Int. 2014 Jan 6. 111 (1-2):12-21; quiz 22. [QxMD MEDLINE Link].
Wilhelm H, Schabet M. The Diagnosis and Treatment of Optic Neuritis. Dtsch Arztebl Int. 2015 Sep 11. 112 (37):616-25; quiz 626. [QxMD MEDLINE Link].
Evans RW, Grosberg BM. Retinal migraine: migraine associated with monocular visual symptoms. Headache. 2008 Jan. 48 (1):142-5. [QxMD MEDLINE Link].
Ing EB, Miller NR, Nguyen A, Su W, Bursztyn LLCD, Poole M, et al. Neural network and logistic regression diagnostic prediction models for giant cell arteritis: development and validation. Clin Ophthalmol. 2019. 13:421-430. [QxMD MEDLINE Link].
Ashraf M, Souka AA, Singh RP. Central retinal vein occlusion: modifying current treatment protocols. Eye (Lond). 2016 Apr. 30 (4):505-14. [QxMD MEDLINE Link].
Rootman DB, Gill HS, Margolin EA. Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial. Eye (Lond). 2013 Feb 1. [QxMD MEDLINE Link].
Dickersin K, Manheimer E, Li T. Surgery for nonarteritic anterior ischemic optic neuropathy. Cochrane Database Syst Rev. 2012 Jan 18. 1:CD001538. [QxMD MEDLINE Link].
Varma R, Bressler NM, Suñer I, et al. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. Ophthalmology. 2012 Oct. 119(10):2108-18. [QxMD MEDLINE Link].
Gal RL, Vedula SS, Beck R. Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev. 2012 Apr 18. 4:CD001430. [QxMD MEDLINE Link].
Biousse V, Calvetti O, Bruce BB, Newman NJ. Thrombolysis for central retinal artery occlusion. J Neuroophthalmol. 2007 Sep. 27(3):215-30. [QxMD MEDLINE Link].
Schumacher M, Schmidt D, Jurklies B, et al. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology. 2010 Jul. 117(7):1367-75.e1. [QxMD MEDLINE Link].
McAllister IL, Gillies ME, Smithies LA, et al. The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion. Ophthalmology. 2010 May. 117(5):954-65. [QxMD MEDLINE Link].
Ferrara DC, Koizumi H, Spaide RF. Early bevacizumab treatment of central retinal vein occlusion. Am J Ophthalmol. 2007 Dec. 144(6):864-71. [QxMD MEDLINE Link].
Wroblewski JJ, Wells JA 3rd, Adamis AP, et al. Pegaptanib sodium for macular edema secondary to central retinal vein occlusion. Arch Ophthalmol. 2009 Apr. 127(4):374-80. [QxMD MEDLINE Link].
D.M. Brown, P.A. Campochiaro, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010. 117:1124-1133. [QxMD MEDLINE Link].
Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, et al. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010. 117(6):1102-12. [QxMD MEDLINE Link].
Campochiaro PA, Brown DM, Awh CC, et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology. 2011 Oct. 118(10):2041-9. [QxMD MEDLINE Link].
Brown DM, Campochiaro PA, Bhisitkul RB, Ho AC, Gray S, Saroj N, et al. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology. 2011. 117(6):1594-602. [QxMD MEDLINE Link].
Heier JS, Campochiaro PA, Yau L, Li Z, Saroj N, Rubio RG, et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology. 2012. 119(4):802-9. [QxMD MEDLINE Link].
Mitry D, Bunce C, Charteris D. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. Cochrane Database Syst Rev. 2013 Jan 31. 1:CD009510. [QxMD MEDLINE Link].
Aldrich EM, Lee AW, Chen CS, et al. Local intra-arterial fibrinolysis administered in aliquots for the treatment of central retinal artery occlusion: the Johns Hopkins Hospital experience. Stroke. 2008 Jun. 39(6):1746-50. [QxMD MEDLINE Link].
Carter JE. Chronic ocular ischemia and carotid vascular disease. Bernestein EF, ed. Amaurosis Fugax. New York: Springer-Verlag; 1988. 118-134.
FDA. US Food and Drug Administration Center for Drug Evaluation and Research [Web site]. Available at https://www.fda.gov/cder/. Accessed: November 2008.
Fisher CM. Observations of the fundus oculi in transient monocular blindness. Neurology. 1959 May. 9(5):333-47. [QxMD MEDLINE Link].
Bowling B. Neuroophthalmology. Kanski's Clinical Ophthalmology: A Systematic Approach. 8th ed. 2016. 790-802.
Feroze KB, O'Rourke MC. Transient Loss Of Vision. 2019 Jan. [QxMD MEDLINE Link]. [Full Text].